Pazopanib activity confirmed in EWSR1-NFATC2 bone sarcoma

A new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, “Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma.”

Mayo Clinic to Deploy Abridge’s AI-Powered Clinical Documentation Across Enterprise

What You Should Know: – Abridge has finalized an enterprise-wide agreement with Mayo Clinic to implement the AI-powered clinical documentation platform, starting with approximately 2,000 clinicians who

January 14, 2025

NIH Scandal Grows; Ancient Skull Shows Brain Surgery; Drugs in New York’s Rivers

Note that some links may require registration or subscription. After a top aide to former National Institute of Allergy and Infectious Diseases director Anthony Fauci,

May 30, 2024

World Health Organization responds to a critical First Opinion

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers,

January 21, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.